AMY AMOROSO: Open Payments
NPI 1073185047 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 45 payments from 13 companies in 2025. Trend: 2023 $799 · 2024 $850 · 2025 $1,000
Food & beverage: $1,000
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $280 |
| Amgen Inc. | 9 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $113 |
| Lilly USA, LLC | 4 | $96 |
| Inspire Medical Systems, Inc. | 1 | $88 |
| Novo Nordisk Inc | 5 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: Kerendia, AIRSUPRA, INSPIRE, MOUNJARO, JARDIANCE, KRYSTEXXA, Ozempic, REPATHA.
Industry payments across CO — which companies pay providers there.
